Chain Drug Review - Lannett fills gap
PHILADELPHIA — Lannett Co. is working to ensure a supply of the heart failure drug digoxin following a recall of another version of the drug. The FDA said that Digitek tablets may contain twice the amount of the active ingredient, which could put patients at risk, including the possibility of death.
Related Results
Digoxin poses risk in womenDetecting digoxin toxicityFDA acts against generic digoxinOmeprazole-associated digoxin toxicity.Impact of Ginkgo biloba on the pharmacokinetics of digoxin - Brief Article
COPYRIGHT 2008 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
